Home Contact
Login   |  Tell a Friend
Financial Optimization through Technology Innovation
mutual fund
 Top Fund Managers
Latest Mutual Fund News Latest Mutual Fund News

Financial Advisor Sponsor:Philip A. White


 Bookmark this site!
Follow FundMojo on Twitter
Get Fund Information

Get Stock News

(Enter Stock Symbol)

Partner Sites

Annuities
Wall Street Journal
eHealthInsurance
Fund Mojo on Facebook
Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | EXLSX Insights | EXLSX Score | EXLSX Performance | EXLSX Manager | EXLSX News | EXLSX Allocation | EXLSX Holdings Change

Mutual Fund Insights: Manning & Napier Life Sciences Fund (EXLSX)

In-depth Analysis of Manning & Napier Life Sciences Fund (EXLSX)

Mutual fund chart: Manning & Napier Life Sciences Fund (EXLSX)

3 months
6 months
1 year
3 year
5 year

See Manning & Napier Life Sciences Fund (EXLSX) performance details as of January 31, 2010

  

    Last Trade: $11.30 on 3/19/2010, Change: +0.02 (0.18%)

  

Fund Manager - Jeffrey S. Coons

Fund Manager Tenure: 10.4 years
Fundmojo Fund Grade: B (Score: 0.64)     (What does this score mean?)
Coons is a senior analyst. He joined Manning & Napier Advisors in 1993. Coons has been a senior analyst and co-director of research since 2002. He has been a member of the Senior Research Group since 1993, and a member of the Executive Group since 1999. He holds the Charted Financial Analyst designation.  Get more insights on Jeffrey S. Coons

  

What we like about Manning & Napier Life Sciences Fund (EXLSX) What we like about Manning & Napier Life Sciences Fund (EXLSX)

Data for Manning & Napier Life Sciences Fund (EXLSX) as of January 31, 2010

  • Manning & Napier Life Sciences Fund (EXLSX) management has been with Manning & Napier Life Sciences Fund for 10.4 years
  • Manning & Napier Life Sciences Fund (EXLSX) has good short-term performance (1-year return 54.52% vs 24.07% Health category average)
  • Manning & Napier Life Sciences Fund (EXLSX) has good Long-term performance (5-year return 6.63% vs 4.22% Health category average)
  • Manning & Napier Life Sciences Fund (EXLSX) ratio of up-years vs down years is greater than 2
  • Manning & Napier Life Sciences Fund (EXLSX) has an annual stock turnover rate of 94.00% vs Health average of 152.72%. It is good that Manning & Napier Life Sciences management does not trade extensively for its return.
  • Manning & Napier Life Sciences Fund (EXLSX) has a lower management fee than its Health average: 1.12% vs 1.91%
  • Manning & Napier Life Sciences Fund (EXLSX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

  

What we are cautious about Manning & Napier Life Sciences Fund (EXLSX) What we are cautious about Manning & Napier Life Sciences Fund (EXLSX)

Data for Manning & Napier Life Sciences Fund (EXLSX) as of January 31, 2010

  • Manning & Napier Life Sciences Fund is a focused fund with 44.11% of the portfolio on top 10 securities. This tends to produce more volatility compared to a diversified fund. See fund top 10 holdings.
  • Manning & Napier Life Sciences Fund (EXLSX) has a less-than-ideal mid-term performance (3-year return -0.26% vs -0.24% Health category average)
  • Manning & Napier Life Sciences Fund (EXLSX) has a Morningstar rating of 3 and below
  • Manning & Napier Life Sciences Fund (EXLSX) is more volatile than its peers as it has a 3-year Standard Deviation of 24.58 that is higher than category average of 18.84
See Manning & Napier Life Sciences Fund (EXLSX) performance details as of January 31, 2010

  

  

Interested in other top mutual funds in similar Health category?

Below are some additional Health mutual funds generated out of our database

  

Manning & Napier Life Sciences Fund (EXLSX) Net Asset

Track net asset change of Manning & Napier Life Sciences fund (EXLSX)

DateNet Asset
01/2010$274.50M
11/2009$258.36M
10/2009$254.56M
More historic net asset information on Manning & Napier Life Sciences Fund (EXLSX)

  

Manning & Napier Life Sciences Fund (EXLSX) Portfolio Allocation

Track portfolio allocation change of Manning & Napier Life Sciences fund (EXLSX)

DateCashStockBondOther
10/20097.99%91.4%0%0.61%
09/200911.79%87.59%0%0.62%
08/20097.3%92.06%0%0.63%
Click here to see more historic asset allocation information on Manning & Napier Life Sciences Fund (EXLSX)

  

Most Recent Top 10 Holdings in Manning & Napier Life Sciences Fund (EXLSX)

Discover what Manning & Napier Life Sciences Fund (EXLSX) manager is buying

31-Oct-09
INVERNESS MED INNOVA [5.12%]
COVIDIEN PLC [4.73%]
Sonic Healthcare Limited [4.57%]
Eclipsys Corporation [4.5%]
Celera Corporation [4.27%]
WELLPOINT INC. [4.1%]
Gen-Probe Incorporated [4.09%]
DENTSPLY International Inc. [4.03%]
UNITEDHEALTH GROUP [4.02%]
AETNA INC. NEW [4.01%]

30-Sep-09
COVIDIEN PLC [5.64%]
INVERNESS MED INNOVA [5.14%]
Eclipsys Corporation [4.57%]
Sonic Healthcare Limited [4.47%]
Dreyfus Cash Management Instl [4.34%]
Celera Corporation [4.23%]
DENTSPLY International Inc. [4.16%]
Gen-Probe Incorporated [4%]
Straumann Holding AG [3.32%]
COACH INC [3.26%]

31-Aug-09
COVIDIEN PLC [5.49%]
INVERNESS MED INNOVA [5.02%]
Celera Corporation [4.73%]
Sonic Healthcare Limited [4.49%]
DENTSPLY International Inc. [4.32%]
DexCom, Inc. [4.3%]
Eclipsys Corporation [4.22%]
Gen-Probe Incorporated [3.96%]
BioMerieux SA [3.67%]
Dreyfus Cash Management Instl [3.54%]
Click here for Stock Holding Change Map in Manning & Napier Life Sciences Fund (EXLSX)

  

Related books and products to Manning & Napier Life Sciences Fund (EXLSX)

  

Latest News on Manning & Napier Life Sciences (EXLSX)

See what is happening with Manning & Napier Life Sciences Fund (EXLSX)

 

Books and Resources

 

 

See more information on Manning & Napier Life Sciences Fund (EXLSX)